|
|
|
|
Direct Cost |
Indirect Cost |
|
1DP2DE023319-01 |
Engineering Biomaterials to Exert Molecular Control of Immune Cell Function |
UNIVERSITY OF CALIFORNIA IRVINE |
NIDCR |
$1,500,000 |
$802,500 |
$2,302,500 |
1F30ES021107-01A1 |
Gene expression responses to air pollution and modification by genetic variation |
UNIVERSITY OF CALIFORNIA IRVINE |
NIEHS |
$36,387 |
|
$36,387 |
1F30MH095432-01A1 |
Cortactin and Spine Dysfunction in Fragile X |
UNIVERSITY OF CALIFORNIA IRVINE |
NIMH |
$32,875 |
|
$32,875 |
1F31CA171791-01 |
Characterizing aberrant alternative-splicing in breast cancer |
UNIVERSITY OF CALIFORNIA IRVINE |
NCI |
$35,293 |
|
$35,293 |
1F31CA171915-01A1 |
Temperature Modulated-Fluorescence Tomography: A New Modality for Cancer Imaging |
UNIVERSITY OF CALIFORNIA IRVINE |
NCI |
$35,293 |
|
$35,293 |
1F31GM100743-01 |
Elucidating the Intricacies of Type II Aromatase/Cyclase Domains |
UNIVERSITY OF CALIFORNIA IRVINE |
NIGMS |
$42,232 |
|
$42,232 |
1F31GM101945-01 |
Biochemical and Proteomic Analyses of Mycobacterial Heme Uptake |
UNIVERSITY OF CALIFORNIA IRVINE |
NIGMS |
$32,365 |
|
$32,365 |
1F31HD074409-01 |
Detection of BMP Signaling In Pre-Implantation Mouse Embryos |
UNIVERSITY OF CALIFORNIA IRVINE |
NICHD |
$35,812 |
|
$35,812 |
1F32DA031520-01A1 |
The Role of a Specific Epigenetic Mechanism in Cocaine-induced Drug-seeking Behav |
UNIVERSITY OF CALIFORNIA IRVINE |
NIDA |
$52,190 |
|
$52,190 |
1F32GM099382-01A1 |
The genetics of the Drosophila IIS pathway response to changing nutrition |
UNIVERSITY OF CALIFORNIA IRVINE |
NIGMS |
$49,214 |
|
$49,214 |
1F32GM103058-01 |
Total Synthesis of Alsmaphorazine A, an Alkaloid Natural Product Inhibitor of Nit |
UNIVERSITY OF CALIFORNIA IRVINE |
NIGMS |
$47,114 |
|
$47,114 |
1K01HD073319-01 |
Why Are Boys Faltering in School? International and Longitudinal Perspectives |
UNIVERSITY OF CALIFORNIA IRVINE |
NICHD |
$118,307 |
$9,465 |
$127,772 |
1P20CA174188-01 |
CSUF and UCI-CFCCC Partnership for Cancer Health Disparities Research (2 of 2) |
UNIVERSITY OF CALIFORNIA IRVINE |
NCI |
$98,055 |
$52,541 |
$150,596 |
1R01AG042444-01A1 |
Vascular Risk Factors and Dementia in the Oldest-Old |
UNIVERSITY OF CALIFORNIA IRVINE |
NIA |
$206,845 |
$87,877 |
$294,722 |
1R01AI093548-01A1 |
Characterization of CCL28,CXCL14, and CXCL17, three mucosal chemokines |
UNIVERSITY OF CALIFORNIA IRVINE |
NIAID |
$250,000 |
$125,881 |
$375,881 |
1R01AI095916-01A1 |
Predicting naturally acquired humoral immunity against malaria |
UNIVERSITY OF CALIFORNIA IRVINE |
NIAID |
$252,399 |
$130,878 |
$383,277 |
1R01AI099190-01 |
Dissecting triazole resistance and transcriptional regulation of ergosterol homeo |
UNIVERSITY OF CALIFORNIA IRVINE |
NIAID |
$412,142 |
$219,981 |
$632,123 |
1R01AI101057-01 |
Guide RNA Binding Complex |
UNIVERSITY OF CALIFORNIA IRVINE |
NIAID |
$250,000 |
$133,542 |
$383,542 |
1R01AI102715-01 |
The impact of antibody and pH on female-to-male SIV infection |
UNIVERSITY OF CALIFORNIA IRVINE |
NIAID |
$602,385 |
$79,676 |
$682,061 |
1R01CA158383-01A1 |
TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance |
UNIVERSITY OF CALIFORNIA IRVINE |
NCI |
$216,640 |
$107,385 |
$324,025 |